Mapping the Progress of Alzheimer’s and Parkinson’s Disease: 51 (Advances in Behavioral Biology, 51) - Image 1

£153.05

Springer Mapping the Progress of Alzheimer’s and Parkinson’s Disease: 51 (Advances in Behavioral Biology, 51)

Name: Mapping the Progress of Alzheimer's and Parkinson's Disease: 51 (Advances in Behavioral Biology, 51)
Brand: Springer
Price: 153.05 GBP
Availability: InStock

Geriatrics

About as cheap as it gets. The only time it was cheaper was 2 months ago.

£153 today · all-time low £153 (May 2026) · usually £153

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 70 days · 70 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 70 days • 2 price levels

Days at Price

Current Price

Price Analysis

Most common price: £153 (55 days, 78.6%)

Price range: £153 - £166

Price levels: 2 different prices over 70 days

Description

1h The 5 International Conference on the Progress in Alzheimer's Disease and Parkinson's 51 1 Disease took place from March 31 to April 5 \ 2001 in Kroto, Japan. This international 1 conference was organized as a joint Congress with the 9 International Catecholamine Symposium. A total of 1258 clinicians and researchers participated in this joint congress 1h from 38 countries in the world. This book represents the proceedings of the 5 Conference on Alzheimer's and Parkinson's disease. The International Conference on the Progress in Alzheimer's and Parkinson's disease was first launched by Professor Abraham Fisher of Israel and Professor Israel Hanin of USA. The first conference was held in Eilat, Israel in 1985. The second conference was organized in Kyoto, Japan in 1989; the third one in Chicago, USA, in 1993, and the fourth one in Eilat, Israel in 1997. The International Catecholamine Symposium (ICS) is an international meeting devoted to the development of basic as well as clinical research on catecholamines. The first Catecholamine Symposium was held in Bethesda, USA in 1958. Since then this symposium has occurred every 5 years. Professor Toshiharu Nagatsu was appointed as 1h the president of the 9 International Catecholamine Symposium, which was to be held in 200 I also in Japan. Therefore, we decided to organize a joint congress of the two meetings, because there is much overlap in research between Alzheimer's disease, Parkinson's disease, and catecholamines. We thank Professor Nagatsu very much for agreeing to organizing this joint congress.

Product Specifications

Brand: Springer
Format: hardcover
ASIN: 0306467631
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Geriatrics
Domain: Amazon UK
Release Date: 31 March 2002
Listed Since: 07 February 2007

Barcode

No barcode data available

Springer Mapping the Progress of Alzheimer’s and Parkinson’s Disease: 51 (Advances in Behavioral Biology, 51)

About as cheap as it gets. The only time it was cheaper was 2 months ago.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Mapping the Progress of Alzheimer’s and Parkinson’s Disease: 51 (Advances in Behavioral Biology)

Catecholamine Research: From Molecular Insights to Clinical Medicine: 53 (Advances in Behavioral Biology, 53)

Catecholamine Research: From Molecular Insights to Clinical Medicine: 53 (Advances in Behavioral Biology, 53)

Neurobiology of DOPA as a Neurotransmitter

Catecholamines II: 90 / 2 (Handbook of Experimental Pharmacology, 90 / 2)

Control of Gene Expression by Catecholamines and the Renin-Angiotensin System: 33 (Developments in Molecular and Cellular Biochemistry, 33)

Catecholamines and the Heart: Recent Advances in Experimental and Clinical Research

Panel Discussions: Third World Congress of Anaesthesiology São Paulo, Brazil · September 1964: 8 (Anaesthesiology and Resuscitation, 8)

Cortico-Subcortical Dynamics in Parkinson’s Disease (Contemporary Neuroscience)

Neurobiology of the Trace Amines: Analytical, Physiological, Pharmacological, Behavioral, and Clinical Aspects: 37 (Polymer Science and Technology Series, 37)

Biochemistry & Histocytochemistry Research Developments (Biochemistry Research Trends Series)

Monoamine Oxidase Inhibitors: Clinical Pharmacology, Benefits, & Potential Health Risks

Progress in Alzheimer’s and Parkinson’s Diseases: 49 (Advances in Behavioral Biology, 49)

Parkinson’s Disease―II: Aging and Neuroendocrine Relationships: 113 (Advances in Experimental Medicine and Biology, 113)

Sigma Receptors: Their Role in Disease and as Therapeutic Targets: 964 (Advances in Experimental Medicine and Biology, 964)

Cortico-Subcortical Dynamics in Parkinson’s Disease (Contemporary Neuroscience)

Horizons in Neuroscience Research: Volume 37

Excitotoxins: Proceedings of an International Symposium held at The Wenner-Gren Center, Stockholm, August 26–27, 1982: 39 (Wenner-Gren Center International Symposium Series)

Staging Neuropsychiatric Disorders: Implications for Etiopathogenesis and Treatment

Alzheimer’s and Parkinson’s Diseases: Recent Developments: 44 (Advances in Behavioral Biology, 44)

Clinical Studies and Therapies in Parkinson's Disease: Translations from Preclinical Models

The Adenosinergic System: A Non-Dopaminergic Target in Parkinson’s Disease: 10 (Current Topics in Neurotoxicity)

Wiley Chemical Biology of Neurodegeneration - Molecular Approach

Springer - Staging Neuropsychiatric Disorders Book